News & Updates
Filter by Specialty:
A sock to detect diabetic, CV complications?
A study presented at EHRA 2024 demonstrated the potential of a sock fitted with a ballistocardiogram (BCG) sensor to predict diabetic complications by identifying foot pressure distribution patterns, as well as to detect cardiovascular issues.
A sock to detect diabetic, CV complications?
22 Apr 2024
People with depression gain most CV benefits from physical activity
Individuals who engage in physical activities (PA) enjoy a reduced risk of cardiovascular disease (CVD), especially those suffering from depression, with a recent study showing that PA acts through the brain’s stress-related activity.
People with depression gain most CV benefits from physical activity
22 Apr 2024
Lower VTE risk seen in atopic dermatitis vs other inflammatory diseases
Atopic dermatitis (AD) does not seem to induce an increase in the risk of venous thromboembolism (VTE) when considering underlying risk factors, suggests a study. Moreover, patients with AD show a lower VTE risk than those with rheumatoid arthritis (RA), Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA), or ankylosing spondylitis (AS).
Lower VTE risk seen in atopic dermatitis vs other inflammatory diseases
22 Apr 2024
PAOLA-1 at 5 years: Maintenance olaparib + bevacizumab support long-term remission in HRD-positive ovarian cancer
Post hoc analysis of the phase III PAOLA-1/ENGOT-ov25 trial reports respective 5-year progression-free survival (PFS) rates of 72 percent vs 28 percent and 5-year overall survival (OS) rates of 88 percent vs 61 percent for maintenance olaparib plus bevacizumab vs bevacizumab alone in lower-risk homologous recombination deficiency (HRD)–positive patients with newly diagnosed advanced ovarian cancer.
